Jordon Everett Whitley, | |
602 David St, Corning, AR 72422-7268 | |
(870) 857-3655 | |
(870) 857-3667 |
Full Name | Jordon Everett Whitley |
---|---|
Gender | Male |
Speciality | Licensed Practical Nurse |
Location | 602 David St, Corning, Arkansas |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1750889226 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
164W00000X | Licensed Practical Nurse | L059563 (Arkansas) | Primary |
Mailing Address | Practice Location Address |
---|---|
Jordon Everett Whitley, 2707 Browns Ln, Jonesboro, AR 72401-7213 Ph: (870) 972-4961 | Jordon Everett Whitley, 602 David St, Corning, AR 72422-7268 Ph: (870) 857-3655 |
News Archive
Based on structural modeling of ribonucleic acid (RNA) and proteins, the researchers from Duke University argue that newly identified regions of positive selection in the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) likely affect species-specific RNA instead of protein function – improving our understanding of the molecular mechanisms responsible for highly unique biological properties of this virus.
BioMimetic Therapeutics, Inc. today reported its financial results as of and for the three and six months ended June 30, 2010. For the three months ended June 30, 2010, the Company reported a net loss of $7.7 million, or $0.35 per diluted share, compared to a net loss of $6.3 million, or $0.32 per diluted share, for the same period in 2009. For the six months ended June 30, 2010, the Company reported a net loss of $16.2 million, or $0.73 per diluted share, compared to a net loss of $14.3 million, or $0.75 per diluted share, for the same period in 2009.
A special issue on sepsis has been released by the publisher Landes Bioscience (Austin, TX USA). The articles contained in this special issue of the journal Virulence have been authored by world-class investigators and provide new insights into both the pathogen-related factors and the host defense mechanisms that lead to septic shock and contribute to its resolution or fatal outcome.
Cancer patients with blood clots - which occur in one of every 200 cancer patients and are the second most common cause of death among cancer patients - gain no benefit from the insertion of an inferior vena cava filter (IVCF) to the anticoagulant medication fondaparinux (Arixtra), according to research presented today at the 14th World Conference on Lung Cancer, hosted by the International Association for the Study of Lung Cancer.
Researchers from North Carolina State University, Sandia National Laboratories, and the University of California, San Diego have developed new technology that uses microneedles to allow doctors to detect real-time chemical changes in the body - and to continuously do so for an extended period of time.
› Verified 2 days ago
Tammy Todd, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 602 David St, Corning, AR 72422 Phone: 870-857-3655 Fax: 870-857-3667 | |
Lindsey R Ervin, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 602 David St, Corning, AR 72422 Phone: 870-857-3655 Fax: 870-857-3667 | |
Melissa Joann Mccarthy, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 602 David St, Corning, AR 72422 Phone: 870-857-3655 | |
Garen Kenneth Thomas, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 602 David St, Corning, AR 72422 Phone: 870-857-3655 Fax: 870-857-3667 | |
Amy Freeman, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 602 David St, Corning, AR 72422 Phone: 870-857-3655 | |
Shanika Lynn Shavers, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 602 David St, Corning, AR 72422 Phone: 870-857-3655 Fax: 870-857-3667 | |
Mr. Brandon Heath Davis, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 602 David St, Corning, AR 72422 Phone: 870-857-3655 Fax: 870-357-3667 |